Sonoma Pharmaceuticals Inc. Revenue 2011–2025
Sonoma Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Sonoma Pharmaceuticals Inc. revenue for the quarter ending December 31, 2025 was 4.3 M, a 22.03% increase year-over-year.
- Sonoma Pharmaceuticals Inc. revenue for the twelve months ending December 31, 2025 was 17.5 M, a 36.55% increase year-over-year.
- Sonoma Pharmaceuticals Inc. annual revenue for 2025 was 14.3 M, a 12.19% increase from 2024.
- Sonoma Pharmaceuticals Inc. annual revenue for 2024 was 12.7 M, a 4.05% decrease from 2023.
- Sonoma Pharmaceuticals Inc. annual revenue for 2023 was 13.3 M, a 5.10% increase from 2022.
- Sonoma Pharmaceuticals Inc. annual revenue for 2022 was 12.6 M.
Sonoma Pharmaceuticals Inc. (SNOA) — Frequently Asked Questions
Sonoma Pharmaceuticals Inc. (SNOA) is a publicly traded US company. It has a market capitalization of $1M. In fiscal 2025 it reported revenue of $14M and net income of -$3M. Explore SNOA's stock price, financial statements, earnings history, margins and key ratios below.
What is Sonoma Pharmaceuticals Inc.'s market cap?
Sonoma Pharmaceuticals Inc. (SNOA) has a market capitalization of $1M.
What is the SNOA stock price?
SNOA trades at $1.09 (-1.80% on the day).
How much revenue does Sonoma Pharmaceuticals Inc. make?
Sonoma Pharmaceuticals Inc. reported revenue of $14M in fiscal 2025.
Is SNOA profitable?
In fiscal 2025, Sonoma Pharmaceuticals Inc. reported net income of -$3M.